Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury

References

Page 1

	Year	Citations
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections Hilary King, Ronald E. Aubert, William H. Herman Diabetes Care	1998	6.3K
Diabetes and cardiovascular disease. The Framingham study William B. Kannel JAMA Heart FailureCoronary Artery DiseaseMetabolic SyndromeDiabetes EpidemiologyCongestive Heart Failure	1979	4K
Diabetes and Cardiovascular Disease William B. Kannel JAMA Heart FailureCardiometabolic RiskPreventive CardiologyCoronary Artery DiseaseDiabetes Epidemiology	1979	2.7K
Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study Mariano J Garcia, Patricia McNamara, Tavia Gordon, Diabetes HypertensionHeart FailureObesityMetabolic SyndromeDiabetes Epidemiology	1974	1.6K
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Timothy J. Kieffer, Christopher H.S. McIntosh, Raymond A. Pederson Endocrinology GlycobiologyPeptide SciencePeptide ChemistryInsulin SignalingIncubation Mixture	1995	1.1K
Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways Kiwon Ban, M. Hossein Noyan-Ashraf, Judith Hoefer, Circulation	2008	1K
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Bernard Thorens Proceedings of the National Academy of Sciences Expression CloningGastric GlandsInsulin SignalingGastrointestinal Peptide HormoneCell Signaling	1992	898
Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes Orville Kolterman, John B. Buse, Mark Fineman, The Journal of Clinical Endocrinology & Metabolism	2003	551
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk, European Heart Journal	2011	538
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 Masayuki Arakawa, Tomoya Mita, Kosuke Azuma, Diabetes	2010	525

Page 1